Global Artificial Intelligence Drug R&D Supply, Demand and Key Producers, 2026-2032
The global Artificial Intelligence Drug R&D market size is expected to reach $ 1325 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032).
Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.
AI-driven drug development is transitioning from 'proof of concept' to 'deliverable productivity.' On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an 'AI + experimental closed loop' (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.
Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving 'more precise enrollment and endpoint selection' to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from 'software subscription' to 'milestone/revenue sharing, joint R&D, and joint pipeline incubation', and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.
This report studies the global Artificial Intelligence Drug R&D demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence Drug R&D, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence Drug R&D that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Intelligence Drug R&D total market, 2021-2032, (USD Million)
Global Artificial Intelligence Drug R&D total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Intelligence Drug R&D total market, key domestic companies, and share, (USD Million)
Global Artificial Intelligence Drug R&D revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Intelligence Drug R&D total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Intelligence Drug R&D total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Intelligence Drug R&D market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Recursion, BenevolentAI, Atomwise, Recursion Pharmaceuticals, DeepMind(Google), Insitro, Owkin, XtalPi, Verge Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence Drug R&D market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Intelligence Drug R&D Market, By Region:
1. How big is the global Artificial Intelligence Drug R&D market?
2. What is the demand of the global Artificial Intelligence Drug R&D market?
3. What is the year over year growth of the global Artificial Intelligence Drug R&D market?
4. What is the total value of the global Artificial Intelligence Drug R&D market?
5. Who are the Major Players in the global Artificial Intelligence Drug R&D market?
6. What are the growth factors driving the market demand?
Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.
AI-driven drug development is transitioning from 'proof of concept' to 'deliverable productivity.' On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an 'AI + experimental closed loop' (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.
Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving 'more precise enrollment and endpoint selection' to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from 'software subscription' to 'milestone/revenue sharing, joint R&D, and joint pipeline incubation', and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.
This report studies the global Artificial Intelligence Drug R&D demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence Drug R&D, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence Drug R&D that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Intelligence Drug R&D total market, 2021-2032, (USD Million)
Global Artificial Intelligence Drug R&D total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Intelligence Drug R&D total market, key domestic companies, and share, (USD Million)
Global Artificial Intelligence Drug R&D revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Intelligence Drug R&D total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Intelligence Drug R&D total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Intelligence Drug R&D market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Recursion, BenevolentAI, Atomwise, Recursion Pharmaceuticals, DeepMind(Google), Insitro, Owkin, XtalPi, Verge Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence Drug R&D market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Intelligence Drug R&D Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Software
- Service
- Target Identification & Validation
- Hit/Lead Discovery
- Clinical Development & Trial Design
- Others
- Machine Learning & Deep Learning
- Generative Models
- Knowledge Graph & NLP
- Multi-omics / Multimodal Modeling
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations(CRO)
- Academic & Research Institutions
- Others
- Insilico Medicine
- Recursion
- BenevolentAI
- Atomwise
- Recursion Pharmaceuticals
- DeepMind(Google)
- Insitro
- Owkin
- XtalPi
- Verge Genomics
- Iktos
- Valo Health
- Standigm
- Relay Therapeutics
- Cyclica
- Isomorphic Labs
- Schrodinger
- Absci
- Genesis Therapeutics
1. How big is the global Artificial Intelligence Drug R&D market?
2. What is the demand of the global Artificial Intelligence Drug R&D market?
3. What is the year over year growth of the global Artificial Intelligence Drug R&D market?
4. What is the total value of the global Artificial Intelligence Drug R&D market?
5. Who are the Major Players in the global Artificial Intelligence Drug R&D market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cyber Forensics Introduction
1.2 World Cyber Forensics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cyber Forensics Total Market by Region (by Headquarter Location)
1.3.1 World Cyber Forensics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cyber Forensics Revenue (2021-2032)
1.3.3 China Based Company Cyber Forensics Revenue (2021-2032)
1.3.4 Europe Based Company Cyber Forensics Revenue (2021-2032)
1.3.5 Japan Based Company Cyber Forensics Revenue (2021-2032)
1.3.6 South Korea Based Company Cyber Forensics Revenue (2021-2032)
1.3.7 ASEAN Based Company Cyber Forensics Revenue (2021-2032)
1.3.8 India Based Company Cyber Forensics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cyber Forensics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cyber Forensics Consumption Value (2021-2032)
2.2 World Cyber Forensics Consumption Value by Region
2.2.1 World Cyber Forensics Consumption Value by Region (2021-2026)
2.2.2 World Cyber Forensics Consumption Value Forecast by Region (2027-2032)
2.3 United States Cyber Forensics Consumption Value (2021-2032)
2.4 China Cyber Forensics Consumption Value (2021-2032)
2.5 Europe Cyber Forensics Consumption Value (2021-2032)
2.6 Japan Cyber Forensics Consumption Value (2021-2032)
2.7 South Korea Cyber Forensics Consumption Value (2021-2032)
2.8 ASEAN Cyber Forensics Consumption Value (2021-2032)
2.9 India Cyber Forensics Consumption Value (2021-2032)
3 WORLD CYBER FORENSICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cyber Forensics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cyber Forensics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cyber Forensics in 2025
3.2.3 Global Concentration Ratios (CR8) for Cyber Forensics in 2025
3.3 Cyber Forensics Company Evaluation Quadrant
3.4 Cyber Forensics Market: Overall Company Footprint Analysis
3.4.1 Cyber Forensics Market: Region Footprint
3.4.2 Cyber Forensics Market: Company Product Type Footprint
3.4.3 Cyber Forensics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cyber Forensics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cyber Forensics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cyber Forensics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cyber Forensics Consumption Value Comparison
4.2.1 United States VS China: Cyber Forensics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cyber Forensics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cyber Forensics Companies and Market Share, 2021-2026
4.3.1 United States Based Cyber Forensics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cyber Forensics Revenue, (2021-2026)
4.4 China Based Companies Cyber Forensics Revenue and Market Share, 2021-2026
4.4.1 China Based Cyber Forensics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cyber Forensics Revenue, (2021-2026)
4.5 Rest of World Based Cyber Forensics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cyber Forensics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cyber Forensics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cyber Forensics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Computer Forensics
5.2.2 Mobile Device Forensics
5.2.3 Network Forensics
5.2.4 Cloud Forensics
5.3 Market Segment by Type
5.3.1 World Cyber Forensics Market Size by Type (2021-2026)
5.3.2 World Cyber Forensics Market Size by Type (2027-2032)
5.3.3 World Cyber Forensics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT MODE
6.1 World Cyber Forensics Market Size Overview by Deployment Mode: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment Mode
6.2.1 On-Premises
6.2.2 Cloud-Based
6.2.3 Hybrid Deployment
6.3 Market Segment by Deployment Mode
6.3.1 World Cyber Forensics Market Size by Deployment Mode (2021-2026)
6.3.2 World Cyber Forensics Market Size by Deployment Mode (2027-2032)
6.3.3 World Cyber Forensics Market Size Market Share by Deployment Mode (2027-2032)
7 MARKET ANALYSIS BY REVENUE MODEL
7.1 World Cyber Forensics Market Size Overview by Revenue Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Revenue Model
7.2.1 Perpetual License
7.2.2 Subscription License
7.2.3 License + Services
7.3 Market Segment by Revenue Model
7.3.1 World Cyber Forensics Market Size by Revenue Model (2021-2026)
7.3.2 World Cyber Forensics Market Size by Revenue Model (2027-2032)
7.3.3 World Cyber Forensics Market Size Market Share by Revenue Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cyber Forensics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Government
8.2.2 Enterprise
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Cyber Forensics Market Size by Application (2021-2026)
8.3.2 World Cyber Forensics Market Size by Application (2027-2032)
8.3.3 World Cyber Forensics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cellebrite
9.1.1 Cellebrite Details
9.1.2 Cellebrite Major Business
9.1.3 Cellebrite Cyber Forensics Product and Services
9.1.4 Cellebrite Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cellebrite Recent Developments/Updates
9.1.6 Cellebrite Competitive Strengths & Weaknesses
9.2 OpenText
9.2.1 OpenText Details
9.2.2 OpenText Major Business
9.2.3 OpenText Cyber Forensics Product and Services
9.2.4 OpenText Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 OpenText Recent Developments/Updates
9.2.6 OpenText Competitive Strengths & Weaknesses
9.3 Magnet Forensics
9.3.1 Magnet Forensics Details
9.3.2 Magnet Forensics Major Business
9.3.3 Magnet Forensics Cyber Forensics Product and Services
9.3.4 Magnet Forensics Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Magnet Forensics Recent Developments/Updates
9.3.6 Magnet Forensics Competitive Strengths & Weaknesses
9.4 AccessData
9.4.1 AccessData Details
9.4.2 AccessData Major Business
9.4.3 AccessData Cyber Forensics Product and Services
9.4.4 AccessData Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 AccessData Recent Developments/Updates
9.4.6 AccessData Competitive Strengths & Weaknesses
9.5 Exterro
9.5.1 Exterro Details
9.5.2 Exterro Major Business
9.5.3 Exterro Cyber Forensics Product and Services
9.5.4 Exterro Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Exterro Recent Developments/Updates
9.5.6 Exterro Competitive Strengths & Weaknesses
9.6 Paraben
9.6.1 Paraben Details
9.6.2 Paraben Major Business
9.6.3 Paraben Cyber Forensics Product and Services
9.6.4 Paraben Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Paraben Recent Developments/Updates
9.6.6 Paraben Competitive Strengths & Weaknesses
9.7 Oxygen Forensics
9.7.1 Oxygen Forensics Details
9.7.2 Oxygen Forensics Major Business
9.7.3 Oxygen Forensics Cyber Forensics Product and Services
9.7.4 Oxygen Forensics Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Oxygen Forensics Recent Developments/Updates
9.7.6 Oxygen Forensics Competitive Strengths & Weaknesses
9.8 MSAB
9.8.1 MSAB Details
9.8.2 MSAB Major Business
9.8.3 MSAB Cyber Forensics Product and Services
9.8.4 MSAB Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 MSAB Recent Developments/Updates
9.8.6 MSAB Competitive Strengths & Weaknesses
9.9 Qi An Xin
9.9.1 Qi An Xin Details
9.9.2 Qi An Xin Major Business
9.9.3 Qi An Xin Cyber Forensics Product and Services
9.9.4 Qi An Xin Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Qi An Xin Recent Developments/Updates
9.9.6 Qi An Xin Competitive Strengths & Weaknesses
9.10 Venustech
9.10.1 Venustech Details
9.10.2 Venustech Major Business
9.10.3 Venustech Cyber Forensics Product and Services
9.10.4 Venustech Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Venustech Recent Developments/Updates
9.10.6 Venustech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cyber Forensics Industry Chain
10.2 Cyber Forensics Upstream Analysis
10.3 Cyber Forensics Midstream Analysis
10.4 Cyber Forensics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cyber Forensics Introduction
1.2 World Cyber Forensics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cyber Forensics Total Market by Region (by Headquarter Location)
1.3.1 World Cyber Forensics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cyber Forensics Revenue (2021-2032)
1.3.3 China Based Company Cyber Forensics Revenue (2021-2032)
1.3.4 Europe Based Company Cyber Forensics Revenue (2021-2032)
1.3.5 Japan Based Company Cyber Forensics Revenue (2021-2032)
1.3.6 South Korea Based Company Cyber Forensics Revenue (2021-2032)
1.3.7 ASEAN Based Company Cyber Forensics Revenue (2021-2032)
1.3.8 India Based Company Cyber Forensics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cyber Forensics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cyber Forensics Consumption Value (2021-2032)
2.2 World Cyber Forensics Consumption Value by Region
2.2.1 World Cyber Forensics Consumption Value by Region (2021-2026)
2.2.2 World Cyber Forensics Consumption Value Forecast by Region (2027-2032)
2.3 United States Cyber Forensics Consumption Value (2021-2032)
2.4 China Cyber Forensics Consumption Value (2021-2032)
2.5 Europe Cyber Forensics Consumption Value (2021-2032)
2.6 Japan Cyber Forensics Consumption Value (2021-2032)
2.7 South Korea Cyber Forensics Consumption Value (2021-2032)
2.8 ASEAN Cyber Forensics Consumption Value (2021-2032)
2.9 India Cyber Forensics Consumption Value (2021-2032)
3 WORLD CYBER FORENSICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cyber Forensics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cyber Forensics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cyber Forensics in 2025
3.2.3 Global Concentration Ratios (CR8) for Cyber Forensics in 2025
3.3 Cyber Forensics Company Evaluation Quadrant
3.4 Cyber Forensics Market: Overall Company Footprint Analysis
3.4.1 Cyber Forensics Market: Region Footprint
3.4.2 Cyber Forensics Market: Company Product Type Footprint
3.4.3 Cyber Forensics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cyber Forensics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cyber Forensics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cyber Forensics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cyber Forensics Consumption Value Comparison
4.2.1 United States VS China: Cyber Forensics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cyber Forensics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cyber Forensics Companies and Market Share, 2021-2026
4.3.1 United States Based Cyber Forensics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cyber Forensics Revenue, (2021-2026)
4.4 China Based Companies Cyber Forensics Revenue and Market Share, 2021-2026
4.4.1 China Based Cyber Forensics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cyber Forensics Revenue, (2021-2026)
4.5 Rest of World Based Cyber Forensics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cyber Forensics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cyber Forensics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cyber Forensics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Computer Forensics
5.2.2 Mobile Device Forensics
5.2.3 Network Forensics
5.2.4 Cloud Forensics
5.3 Market Segment by Type
5.3.1 World Cyber Forensics Market Size by Type (2021-2026)
5.3.2 World Cyber Forensics Market Size by Type (2027-2032)
5.3.3 World Cyber Forensics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT MODE
6.1 World Cyber Forensics Market Size Overview by Deployment Mode: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment Mode
6.2.1 On-Premises
6.2.2 Cloud-Based
6.2.3 Hybrid Deployment
6.3 Market Segment by Deployment Mode
6.3.1 World Cyber Forensics Market Size by Deployment Mode (2021-2026)
6.3.2 World Cyber Forensics Market Size by Deployment Mode (2027-2032)
6.3.3 World Cyber Forensics Market Size Market Share by Deployment Mode (2027-2032)
7 MARKET ANALYSIS BY REVENUE MODEL
7.1 World Cyber Forensics Market Size Overview by Revenue Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Revenue Model
7.2.1 Perpetual License
7.2.2 Subscription License
7.2.3 License + Services
7.3 Market Segment by Revenue Model
7.3.1 World Cyber Forensics Market Size by Revenue Model (2021-2026)
7.3.2 World Cyber Forensics Market Size by Revenue Model (2027-2032)
7.3.3 World Cyber Forensics Market Size Market Share by Revenue Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cyber Forensics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Government
8.2.2 Enterprise
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Cyber Forensics Market Size by Application (2021-2026)
8.3.2 World Cyber Forensics Market Size by Application (2027-2032)
8.3.3 World Cyber Forensics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cellebrite
9.1.1 Cellebrite Details
9.1.2 Cellebrite Major Business
9.1.3 Cellebrite Cyber Forensics Product and Services
9.1.4 Cellebrite Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cellebrite Recent Developments/Updates
9.1.6 Cellebrite Competitive Strengths & Weaknesses
9.2 OpenText
9.2.1 OpenText Details
9.2.2 OpenText Major Business
9.2.3 OpenText Cyber Forensics Product and Services
9.2.4 OpenText Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 OpenText Recent Developments/Updates
9.2.6 OpenText Competitive Strengths & Weaknesses
9.3 Magnet Forensics
9.3.1 Magnet Forensics Details
9.3.2 Magnet Forensics Major Business
9.3.3 Magnet Forensics Cyber Forensics Product and Services
9.3.4 Magnet Forensics Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Magnet Forensics Recent Developments/Updates
9.3.6 Magnet Forensics Competitive Strengths & Weaknesses
9.4 AccessData
9.4.1 AccessData Details
9.4.2 AccessData Major Business
9.4.3 AccessData Cyber Forensics Product and Services
9.4.4 AccessData Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 AccessData Recent Developments/Updates
9.4.6 AccessData Competitive Strengths & Weaknesses
9.5 Exterro
9.5.1 Exterro Details
9.5.2 Exterro Major Business
9.5.3 Exterro Cyber Forensics Product and Services
9.5.4 Exterro Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Exterro Recent Developments/Updates
9.5.6 Exterro Competitive Strengths & Weaknesses
9.6 Paraben
9.6.1 Paraben Details
9.6.2 Paraben Major Business
9.6.3 Paraben Cyber Forensics Product and Services
9.6.4 Paraben Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Paraben Recent Developments/Updates
9.6.6 Paraben Competitive Strengths & Weaknesses
9.7 Oxygen Forensics
9.7.1 Oxygen Forensics Details
9.7.2 Oxygen Forensics Major Business
9.7.3 Oxygen Forensics Cyber Forensics Product and Services
9.7.4 Oxygen Forensics Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Oxygen Forensics Recent Developments/Updates
9.7.6 Oxygen Forensics Competitive Strengths & Weaknesses
9.8 MSAB
9.8.1 MSAB Details
9.8.2 MSAB Major Business
9.8.3 MSAB Cyber Forensics Product and Services
9.8.4 MSAB Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 MSAB Recent Developments/Updates
9.8.6 MSAB Competitive Strengths & Weaknesses
9.9 Qi An Xin
9.9.1 Qi An Xin Details
9.9.2 Qi An Xin Major Business
9.9.3 Qi An Xin Cyber Forensics Product and Services
9.9.4 Qi An Xin Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Qi An Xin Recent Developments/Updates
9.9.6 Qi An Xin Competitive Strengths & Weaknesses
9.10 Venustech
9.10.1 Venustech Details
9.10.2 Venustech Major Business
9.10.3 Venustech Cyber Forensics Product and Services
9.10.4 Venustech Cyber Forensics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Venustech Recent Developments/Updates
9.10.6 Venustech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cyber Forensics Industry Chain
10.2 Cyber Forensics Upstream Analysis
10.3 Cyber Forensics Midstream Analysis
10.4 Cyber Forensics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Artificial Intelligence Drug R&D Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence Drug R&D Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence Drug R&D Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence Drug R&D Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Intelligence Drug R&D Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence Drug R&D Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Intelligence Drug R&D Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Intelligence Drug R&D Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Intelligence Drug R&D Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence Drug R&D Players in 2025
Table 12. World Artificial Intelligence Drug R&D Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Intelligence Drug R&D Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence Drug R&D Players
Table 15. Artificial Intelligence Drug R&D Market: Company Product Type Footprint
Table 16. Artificial Intelligence Drug R&D Market: Company Product Application Footprint
Table 17. Artificial Intelligence Drug R&D Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence Drug R&D Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Intelligence Drug R&D Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Intelligence Drug R&D Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence Drug R&D Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence Drug R&D Revenue Market Share (2021-2026)
Table 23. China Based Artificial Intelligence Drug R&D Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence Drug R&D Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Intelligence Drug R&D Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Intelligence Drug R&D Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Intelligence Drug R&D Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence Drug R&D Revenue Market Share (2021-2026)
Table 29. World Artificial Intelligence Drug R&D Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Intelligence Drug R&D Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Intelligence Drug R&D Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Intelligence Drug R&D Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Intelligence Drug R&D Market Size Value by Stage (2021-2026) & (USD Million)
Table 34. World Artificial Intelligence Drug R&D Market Size by Stage (2027-2032) & (USD Million)
Table 35. World Artificial Intelligence Drug R&D Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Intelligence Drug R&D Market Size Value by Technology (2021-2026) & (USD Million)
Table 37. World Artificial Intelligence Drug R&D Market Size by Technology (2027-2032) & (USD Million)
Table 38. World Artificial Intelligence Drug R&D Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & (USD Million)
Table 40. World Artificial Intelligence Drug R&D Market Size by Application (2027-2032) & (USD Million)
Table 41. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 42. Insilico Medicine Major Business
Table 43. Insilico Medicine Artificial Intelligence Drug R&D Product and Services
Table 44. Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Insilico Medicine Recent Developments/Updates
Table 46. Insilico Medicine Competitive Strengths & Weaknesses
Table 47. Recursion Basic Information, Manufacturing Base and Competitors
Table 48. Recursion Major Business
Table 49. Recursion Artificial Intelligence Drug R&D Product and Services
Table 50. Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Recursion Recent Developments/Updates
Table 52. Recursion Competitive Strengths & Weaknesses
Table 53. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 54. BenevolentAI Major Business
Table 55. BenevolentAI Artificial Intelligence Drug R&D Product and Services
Table 56. BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BenevolentAI Recent Developments/Updates
Table 58. BenevolentAI Competitive Strengths & Weaknesses
Table 59. Atomwise Basic Information, Manufacturing Base and Competitors
Table 60. Atomwise Major Business
Table 61. Atomwise Artificial Intelligence Drug R&D Product and Services
Table 62. Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Atomwise Recent Developments/Updates
Table 64. Atomwise Competitive Strengths & Weaknesses
Table 65. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Recursion Pharmaceuticals Major Business
Table 67. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product and Services
Table 68. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Recursion Pharmaceuticals Recent Developments/Updates
Table 70. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. DeepMind(Google) Basic Information, Manufacturing Base and Competitors
Table 72. DeepMind(Google) Major Business
Table 73. DeepMind(Google) Artificial Intelligence Drug R&D Product and Services
Table 74. DeepMind(Google) Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. DeepMind(Google) Recent Developments/Updates
Table 76. DeepMind(Google) Competitive Strengths & Weaknesses
Table 77. Insitro Basic Information, Manufacturing Base and Competitors
Table 78. Insitro Major Business
Table 79. Insitro Artificial Intelligence Drug R&D Product and Services
Table 80. Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Insitro Recent Developments/Updates
Table 82. Insitro Competitive Strengths & Weaknesses
Table 83. Owkin Basic Information, Manufacturing Base and Competitors
Table 84. Owkin Major Business
Table 85. Owkin Artificial Intelligence Drug R&D Product and Services
Table 86. Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Owkin Recent Developments/Updates
Table 88. Owkin Competitive Strengths & Weaknesses
Table 89. XtalPi Basic Information, Manufacturing Base and Competitors
Table 90. XtalPi Major Business
Table 91. XtalPi Artificial Intelligence Drug R&D Product and Services
Table 92. XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. XtalPi Recent Developments/Updates
Table 94. XtalPi Competitive Strengths & Weaknesses
Table 95. Verge Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Verge Genomics Major Business
Table 97. Verge Genomics Artificial Intelligence Drug R&D Product and Services
Table 98. Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Verge Genomics Recent Developments/Updates
Table 100. Verge Genomics Competitive Strengths & Weaknesses
Table 101. Iktos Basic Information, Manufacturing Base and Competitors
Table 102. Iktos Major Business
Table 103. Iktos Artificial Intelligence Drug R&D Product and Services
Table 104. Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Iktos Recent Developments/Updates
Table 106. Iktos Competitive Strengths & Weaknesses
Table 107. Valo Health Basic Information, Manufacturing Base and Competitors
Table 108. Valo Health Major Business
Table 109. Valo Health Artificial Intelligence Drug R&D Product and Services
Table 110. Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Valo Health Recent Developments/Updates
Table 112. Valo Health Competitive Strengths & Weaknesses
Table 113. Standigm Basic Information, Manufacturing Base and Competitors
Table 114. Standigm Major Business
Table 115. Standigm Artificial Intelligence Drug R&D Product and Services
Table 116. Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Standigm Recent Developments/Updates
Table 118. Standigm Competitive Strengths & Weaknesses
Table 119. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 120. Relay Therapeutics Major Business
Table 121. Relay Therapeutics Artificial Intelligence Drug R&D Product and Services
Table 122. Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Relay Therapeutics Recent Developments/Updates
Table 124. Relay Therapeutics Competitive Strengths & Weaknesses
Table 125. Cyclica Basic Information, Manufacturing Base and Competitors
Table 126. Cyclica Major Business
Table 127. Cyclica Artificial Intelligence Drug R&D Product and Services
Table 128. Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Cyclica Recent Developments/Updates
Table 130. Cyclica Competitive Strengths & Weaknesses
Table 131. Isomorphic Labs Basic Information, Manufacturing Base and Competitors
Table 132. Isomorphic Labs Major Business
Table 133. Isomorphic Labs Artificial Intelligence Drug R&D Product and Services
Table 134. Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Isomorphic Labs Recent Developments/Updates
Table 136. Isomorphic Labs Competitive Strengths & Weaknesses
Table 137. Schrodinger Basic Information, Manufacturing Base and Competitors
Table 138. Schrodinger Major Business
Table 139. Schrodinger Artificial Intelligence Drug R&D Product and Services
Table 140. Schrodinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Schrodinger Recent Developments/Updates
Table 142. Schrodinger Competitive Strengths & Weaknesses
Table 143. Absci Basic Information, Manufacturing Base and Competitors
Table 144. Absci Major Business
Table 145. Absci Artificial Intelligence Drug R&D Product and Services
Table 146. Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Absci Recent Developments/Updates
Table 148. Absci Competitive Strengths & Weaknesses
Table 149. Genesis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 150. Genesis Therapeutics Major Business
Table 151. Genesis Therapeutics Artificial Intelligence Drug R&D Product and Services
Table 152. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Genesis Therapeutics Recent Developments/Updates
Table 154. Genesis Therapeutics Competitive Strengths & Weaknesses
Table 155. Global Key Players of Artificial Intelligence Drug R&D Upstream (Raw Materials)
Table 156. Global Artificial Intelligence Drug R&D Typical Customers
Table 1. World Artificial Intelligence Drug R&D Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence Drug R&D Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence Drug R&D Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence Drug R&D Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Intelligence Drug R&D Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence Drug R&D Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Intelligence Drug R&D Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Intelligence Drug R&D Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Intelligence Drug R&D Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence Drug R&D Players in 2025
Table 12. World Artificial Intelligence Drug R&D Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Intelligence Drug R&D Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence Drug R&D Players
Table 15. Artificial Intelligence Drug R&D Market: Company Product Type Footprint
Table 16. Artificial Intelligence Drug R&D Market: Company Product Application Footprint
Table 17. Artificial Intelligence Drug R&D Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence Drug R&D Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Intelligence Drug R&D Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Intelligence Drug R&D Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence Drug R&D Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence Drug R&D Revenue Market Share (2021-2026)
Table 23. China Based Artificial Intelligence Drug R&D Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence Drug R&D Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Intelligence Drug R&D Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Intelligence Drug R&D Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Intelligence Drug R&D Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence Drug R&D Revenue Market Share (2021-2026)
Table 29. World Artificial Intelligence Drug R&D Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Intelligence Drug R&D Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Intelligence Drug R&D Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Intelligence Drug R&D Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Intelligence Drug R&D Market Size Value by Stage (2021-2026) & (USD Million)
Table 34. World Artificial Intelligence Drug R&D Market Size by Stage (2027-2032) & (USD Million)
Table 35. World Artificial Intelligence Drug R&D Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Intelligence Drug R&D Market Size Value by Technology (2021-2026) & (USD Million)
Table 37. World Artificial Intelligence Drug R&D Market Size by Technology (2027-2032) & (USD Million)
Table 38. World Artificial Intelligence Drug R&D Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & (USD Million)
Table 40. World Artificial Intelligence Drug R&D Market Size by Application (2027-2032) & (USD Million)
Table 41. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 42. Insilico Medicine Major Business
Table 43. Insilico Medicine Artificial Intelligence Drug R&D Product and Services
Table 44. Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Insilico Medicine Recent Developments/Updates
Table 46. Insilico Medicine Competitive Strengths & Weaknesses
Table 47. Recursion Basic Information, Manufacturing Base and Competitors
Table 48. Recursion Major Business
Table 49. Recursion Artificial Intelligence Drug R&D Product and Services
Table 50. Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Recursion Recent Developments/Updates
Table 52. Recursion Competitive Strengths & Weaknesses
Table 53. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 54. BenevolentAI Major Business
Table 55. BenevolentAI Artificial Intelligence Drug R&D Product and Services
Table 56. BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BenevolentAI Recent Developments/Updates
Table 58. BenevolentAI Competitive Strengths & Weaknesses
Table 59. Atomwise Basic Information, Manufacturing Base and Competitors
Table 60. Atomwise Major Business
Table 61. Atomwise Artificial Intelligence Drug R&D Product and Services
Table 62. Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Atomwise Recent Developments/Updates
Table 64. Atomwise Competitive Strengths & Weaknesses
Table 65. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Recursion Pharmaceuticals Major Business
Table 67. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product and Services
Table 68. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Recursion Pharmaceuticals Recent Developments/Updates
Table 70. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. DeepMind(Google) Basic Information, Manufacturing Base and Competitors
Table 72. DeepMind(Google) Major Business
Table 73. DeepMind(Google) Artificial Intelligence Drug R&D Product and Services
Table 74. DeepMind(Google) Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. DeepMind(Google) Recent Developments/Updates
Table 76. DeepMind(Google) Competitive Strengths & Weaknesses
Table 77. Insitro Basic Information, Manufacturing Base and Competitors
Table 78. Insitro Major Business
Table 79. Insitro Artificial Intelligence Drug R&D Product and Services
Table 80. Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Insitro Recent Developments/Updates
Table 82. Insitro Competitive Strengths & Weaknesses
Table 83. Owkin Basic Information, Manufacturing Base and Competitors
Table 84. Owkin Major Business
Table 85. Owkin Artificial Intelligence Drug R&D Product and Services
Table 86. Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Owkin Recent Developments/Updates
Table 88. Owkin Competitive Strengths & Weaknesses
Table 89. XtalPi Basic Information, Manufacturing Base and Competitors
Table 90. XtalPi Major Business
Table 91. XtalPi Artificial Intelligence Drug R&D Product and Services
Table 92. XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. XtalPi Recent Developments/Updates
Table 94. XtalPi Competitive Strengths & Weaknesses
Table 95. Verge Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Verge Genomics Major Business
Table 97. Verge Genomics Artificial Intelligence Drug R&D Product and Services
Table 98. Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Verge Genomics Recent Developments/Updates
Table 100. Verge Genomics Competitive Strengths & Weaknesses
Table 101. Iktos Basic Information, Manufacturing Base and Competitors
Table 102. Iktos Major Business
Table 103. Iktos Artificial Intelligence Drug R&D Product and Services
Table 104. Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Iktos Recent Developments/Updates
Table 106. Iktos Competitive Strengths & Weaknesses
Table 107. Valo Health Basic Information, Manufacturing Base and Competitors
Table 108. Valo Health Major Business
Table 109. Valo Health Artificial Intelligence Drug R&D Product and Services
Table 110. Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Valo Health Recent Developments/Updates
Table 112. Valo Health Competitive Strengths & Weaknesses
Table 113. Standigm Basic Information, Manufacturing Base and Competitors
Table 114. Standigm Major Business
Table 115. Standigm Artificial Intelligence Drug R&D Product and Services
Table 116. Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Standigm Recent Developments/Updates
Table 118. Standigm Competitive Strengths & Weaknesses
Table 119. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 120. Relay Therapeutics Major Business
Table 121. Relay Therapeutics Artificial Intelligence Drug R&D Product and Services
Table 122. Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Relay Therapeutics Recent Developments/Updates
Table 124. Relay Therapeutics Competitive Strengths & Weaknesses
Table 125. Cyclica Basic Information, Manufacturing Base and Competitors
Table 126. Cyclica Major Business
Table 127. Cyclica Artificial Intelligence Drug R&D Product and Services
Table 128. Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Cyclica Recent Developments/Updates
Table 130. Cyclica Competitive Strengths & Weaknesses
Table 131. Isomorphic Labs Basic Information, Manufacturing Base and Competitors
Table 132. Isomorphic Labs Major Business
Table 133. Isomorphic Labs Artificial Intelligence Drug R&D Product and Services
Table 134. Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Isomorphic Labs Recent Developments/Updates
Table 136. Isomorphic Labs Competitive Strengths & Weaknesses
Table 137. Schrodinger Basic Information, Manufacturing Base and Competitors
Table 138. Schrodinger Major Business
Table 139. Schrodinger Artificial Intelligence Drug R&D Product and Services
Table 140. Schrodinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Schrodinger Recent Developments/Updates
Table 142. Schrodinger Competitive Strengths & Weaknesses
Table 143. Absci Basic Information, Manufacturing Base and Competitors
Table 144. Absci Major Business
Table 145. Absci Artificial Intelligence Drug R&D Product and Services
Table 146. Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Absci Recent Developments/Updates
Table 148. Absci Competitive Strengths & Weaknesses
Table 149. Genesis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 150. Genesis Therapeutics Major Business
Table 151. Genesis Therapeutics Artificial Intelligence Drug R&D Product and Services
Table 152. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Genesis Therapeutics Recent Developments/Updates
Table 154. Genesis Therapeutics Competitive Strengths & Weaknesses
Table 155. Global Key Players of Artificial Intelligence Drug R&D Upstream (Raw Materials)
Table 156. Global Artificial Intelligence Drug R&D Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug R&D Picture
Figure 2. World Artificial Intelligence Drug R&D Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Intelligence Drug R&D Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Intelligence Drug R&D Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Intelligence Drug R&D Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Intelligence Drug R&D Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence Drug R&D by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence Drug R&D Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence Drug R&D Markets in 2025
Figure 27. United States VS China: Artificial Intelligence Drug R&D Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Intelligence Drug R&D Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Intelligence Drug R&D Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Intelligence Drug R&D Market Size Market Share by Type in 2025
Figure 31. Software
Figure 32. Service
Figure 33. World Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2032)
Figure 34. World Artificial Intelligence Drug R&D Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Figure 35. World Artificial Intelligence Drug R&D Market Size Market Share by Stage in 2025
Figure 36. Target Identification & Validation
Figure 37. Hit/Lead Discovery
Figure 38. Clinical Development & Trial Design
Figure 39. Others
Figure 40. World Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2032)
Figure 41. World Artificial Intelligence Drug R&D Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 42. World Artificial Intelligence Drug R&D Market Size Market Share by Technology in 2025
Figure 43. Machine Learning & Deep Learning
Figure 44. Generative Models
Figure 45. Knowledge Graph & NLP
Figure 46. Multi-omics / Multimodal Modeling
Figure 47. World Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2032)
Figure 48. World Artificial Intelligence Drug R&D Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Artificial Intelligence Drug R&D Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical Companies
Figure 51. Biotechnology Companies
Figure 52. Contract Research Organizations(CRO)
Figure 53. Academic & Research Institutions
Figure 54. Others
Figure 55. World Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2032)
Figure 56. Artificial Intelligence Drug R&D Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Artificial Intelligence Drug R&D Picture
Figure 2. World Artificial Intelligence Drug R&D Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Intelligence Drug R&D Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Intelligence Drug R&D Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Intelligence Drug R&D Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Intelligence Drug R&D Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Intelligence Drug R&D Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence Drug R&D by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence Drug R&D Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence Drug R&D Markets in 2025
Figure 27. United States VS China: Artificial Intelligence Drug R&D Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Intelligence Drug R&D Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Intelligence Drug R&D Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Intelligence Drug R&D Market Size Market Share by Type in 2025
Figure 31. Software
Figure 32. Service
Figure 33. World Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2032)
Figure 34. World Artificial Intelligence Drug R&D Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Figure 35. World Artificial Intelligence Drug R&D Market Size Market Share by Stage in 2025
Figure 36. Target Identification & Validation
Figure 37. Hit/Lead Discovery
Figure 38. Clinical Development & Trial Design
Figure 39. Others
Figure 40. World Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2032)
Figure 41. World Artificial Intelligence Drug R&D Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 42. World Artificial Intelligence Drug R&D Market Size Market Share by Technology in 2025
Figure 43. Machine Learning & Deep Learning
Figure 44. Generative Models
Figure 45. Knowledge Graph & NLP
Figure 46. Multi-omics / Multimodal Modeling
Figure 47. World Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2032)
Figure 48. World Artificial Intelligence Drug R&D Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Artificial Intelligence Drug R&D Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical Companies
Figure 51. Biotechnology Companies
Figure 52. Contract Research Organizations(CRO)
Figure 53. Academic & Research Institutions
Figure 54. Others
Figure 55. World Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2032)
Figure 56. Artificial Intelligence Drug R&D Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
